Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma

ISSN:
1432-1335
Keywords:
Malignant melanoma ; Chemotherapy
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Summary Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment.
Type of Medium:
Electronic Resource
URL:
_version_ 1798295652286857216
autor Mulder, N. H.
Sleijfer, D. Th.
Vries, E. G. E.
Koops, H. Schraffordt
Willemse, P. H. B.
autorsonst Mulder, N. H.
Sleijfer, D. Th.
Vries, E. G. E.
Koops, H. Schraffordt
Willemse, P. H. B.
book_url http://dx.doi.org/10.1007/BF01612907
datenlieferant nat_lic_papers
hauptsatz hsatz_simple
identnr NLM205268714
issn 1432-1335
journal_name Journal of cancer research and clinical oncology
materialart 1
notes Summary Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment.
package_name Springer
publikationsjahr_anzeige 1990
publikationsjahr_facette 1990
publikationsjahr_intervall 8009:1990-1994
publikationsjahr_sort 1990
publisher Springer
reference 116 (1990), S. 301-302
schlagwort Malignant melanoma
Chemotherapy
search_space articles
shingle_author_1 Mulder, N. H.
Sleijfer, D. Th.
Vries, E. G. E.
Koops, H. Schraffordt
Willemse, P. H. B.
shingle_author_2 Mulder, N. H.
Sleijfer, D. Th.
Vries, E. G. E.
Koops, H. Schraffordt
Willemse, P. H. B.
shingle_author_3 Mulder, N. H.
Sleijfer, D. Th.
Vries, E. G. E.
Koops, H. Schraffordt
Willemse, P. H. B.
shingle_author_4 Mulder, N. H.
Sleijfer, D. Th.
Vries, E. G. E.
Koops, H. Schraffordt
Willemse, P. H. B.
shingle_catch_all_1 Mulder, N. H.
Sleijfer, D. Th.
Vries, E. G. E.
Koops, H. Schraffordt
Willemse, P. H. B.
Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma
Malignant melanoma
Chemotherapy
Malignant melanoma
Chemotherapy
Summary Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment.
1432-1335
14321335
Springer
shingle_catch_all_2 Mulder, N. H.
Sleijfer, D. Th.
Vries, E. G. E.
Koops, H. Schraffordt
Willemse, P. H. B.
Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma
Malignant melanoma
Chemotherapy
Malignant melanoma
Chemotherapy
Summary Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment.
1432-1335
14321335
Springer
shingle_catch_all_3 Mulder, N. H.
Sleijfer, D. Th.
Vries, E. G. E.
Koops, H. Schraffordt
Willemse, P. H. B.
Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma
Malignant melanoma
Chemotherapy
Malignant melanoma
Chemotherapy
Summary Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment.
1432-1335
14321335
Springer
shingle_catch_all_4 Mulder, N. H.
Sleijfer, D. Th.
Vries, E. G. E.
Koops, H. Schraffordt
Willemse, P. H. B.
Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma
Malignant melanoma
Chemotherapy
Malignant melanoma
Chemotherapy
Summary Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment.
1432-1335
14321335
Springer
shingle_title_1 Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma
shingle_title_2 Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma
shingle_title_3 Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma
shingle_title_4 Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Springer Online Journal Archives 1860-2000
timestamp 2024-05-06T09:39:36.518Z
titel Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma
titel_suche Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma
topic WW-YZ
uid nat_lic_papers_NLM205268714